

Smad8 Antibody (3E5) is a mouse monoclonal IgG2a kappa light chain antibody that detects the Smad8 protein of human origin by western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). anti-Smad8 antibody (3E5) is available as a non-conjugated isotype antibody. Smad8, also known as Smad9 or MADH6, plays a crucial role in the bone morphogenetic protein (BMP) signaling pathway, which is essential for various cellular processes, including embryonic development, cell differentiation, and tissue homeostasis. Located primarily in the cytoplasm and nucleus, Smad8 transduces signals from BMP receptors to the nucleus, where Smad8 regulates gene expression. This localization allows Smad8 to act as a transcriptional regulator, influencing the expression of target genes involved in developmental processes and cellular responses to environmental cues. Proper functioning of Smad8 is critical, as dysregulation of BMP signaling has been implicated in various diseases, including cancer and fibrotic disorders. Using Smad8 (3E5) antibody in research can provide insights into the mechanisms of BMP signaling and its implications in health and disease.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Smad8 Antibody (3E5) | sc-293413 | 100 µg/ml | $322.00 |